Similar companies
| Company | Stocktwits Mentions | |
|---|---|---|
 |
AmgenAMGN |
14 0% |
 |
Gilead SciencesGILD |
11 8.3% |
 |
Catalyst PharmaceuticalsCPRX |
0 0% |
 |
Inovio PharmaceuticalsINO |
167 7.7% |
 |
Anavex Life SciencesAVXL |
185 10.1% |
GLUE Stocktwits Mention Trend
Monte Rosa Therapeutics (GLUE) is averaging 43 mentions a day on Stocktwits, up 187% from three months ago, a sign of elevated retail interest. Mention volume is spiky by nature, tending to surge around earnings, news, and price breakouts, so day-to-day swings are normal.
At 43 mentions a day, Monte Rosa Therapeutics draws more daily Stocktwits chatter than industry peers like Amgen (14 a day) and Gilead Sciences (11 a day).
What Do Stocktwits Mentions Say About GLUE Sentiment?
Stocktwits sentiment for GLUE: 100 / 100 — Bullish. This is the bullish-versus-bearish balance of Stocktwits posts specifically; for the blended average across Reddit, StockTwits, and TipRanks, see GLUE overall sentiment.
Mention volume is a real-time read on retail interest: a sustained pickup in Stocktwits chatter often reflects shifting attention toward a stock, though it does not say which way the price will move — that is what the Stocktwits sentiment score above captures. AltIndex feeds Monte Rosa Therapeutics’s Stocktwits activity into the GLUE AI Score as one of 25+ alternative data signals, weighed against Reddit and X chatter, fundamentals, and more.
For social activity on other platforms, see GLUE Reddit mentions and GLUE X mentions. For the size of the community following the stock, see GLUE Stocktwits subscribers. To see which tickers are most talked about, view the most mentioned Stocktwits stocks.
Month over Month
| Sep 2026 | 4 | |
| Aug 2026 | 9 | |
| Jul 2026 | 10 | |
| Jun 2026 | 6 | |
| May 2026 | 2 |
Monte Rosa Therapeutics Stocktwits Mentions: Frequently Asked Questions
Monte Rosa Therapeutics (GLUE) is averaging 43 mentions a day on Stocktwits. Mention volume is event-driven, so it tends to spike around earnings, news, and sharp price moves rather than holding steady.
See the GLUE Stocktwits subscriber count for the size of the community tracking the stock — a more stable figure than daily mention volume.
Stocktwits mention volume is a proxy for real-time retail interest. A spike often flags an earnings reaction, news event, or price breakout, but on its own it does not predict direction. That is why AltIndex combines GLUE’s Stocktwits chatter with sentiment, Reddit and X mentions, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Monte Rosa Therapeutics underperforms its industry peers when it comes to Stocktwits Mentions, ranking in the 1st percentile.
AltIndex updates the data on Monte Rosa Therapeutics' mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Monte Rosa Therapeutics' on the platform.
Sign up and get more insights on Monte Rosa Therapeutics.
See Monte Rosa Therapeutics’s complete stocktwits mentions history
Sign up to unlock 1-year and all-time charts for GLUE, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
